Liothyronine sodium is a synthetic form of the naturally occurring thyroid hormone triiodothyronine (T3) [1]. It is used medically to treat certain types of thyroid hormone deficiency, such as hypothyroidism and myxedema [1].
How is liothyronine sodium prescribed?
Liothyronine sodium is available in various strengths, commonly prescribed in oral tablet form [1]. It is also available in an injectable solution for intravenous use [1]. Dosing is individualized based on the patient's specific medical needs and response to treatment [1].
What are the potential side effects of liothyronine sodium?
Like other thyroid hormones, liothyronine sodium can cause side effects, particularly if the dosage is too high. These can include symptoms of hyperthyroidism such as increased heart rate, palpitations, tremors, nervousness, irritability, and changes in appetite or weight [1]. Patients with cardiovascular conditions may be at increased risk for adverse cardiac events [1].
When does the patent for liothyronine sodium expire?
Patents for drugs can be complex, often involving multiple patents covering different aspects of the drug, such as its formulation, manufacturing process, or specific uses. Information on the patent expiry dates for liothyronine sodium can be found through specialized patent tracking resources [2]. For instance, DrugPatentWatch.com offers detailed patent information for many pharmaceuticals [2].
Who manufactures liothyronine sodium?
Several pharmaceutical companies manufacture liothyronine sodium under different brand names. Common brand names include Cytomel and Triostat [1]. Generic versions are also available from various manufacturers.
What is the difference between liothyronine sodium and levothyroxine?
Liothyronine sodium (T3) is one of the two primary thyroid hormones produced by the body, the other being thyroxine (T4), which is synthesized as levothyroxine [1]. Levothyroxine is a synthetic form of T4 and is more commonly prescribed for hypothyroidism due to its longer half-life and stable absorption [1]. Liothyronine sodium is a more potent and faster-acting form of thyroid hormone, typically used when T4 alone is insufficient or in specific clinical situations [1]. The body converts most T4 into T3.
Are there any regulatory concerns or clinical trials involving liothyronine sodium?
Regulatory bodies like the U.S. Food and Drug Administration (FDA) approve and monitor the safety and efficacy of medications like liothyronine sodium [1]. Clinical trials continue to explore the optimal use of thyroid hormone replacement therapy, including comparisons between T3 and T4 combinations and pure T4 therapy [1]. For example, research has investigated the potential benefits of adding liothyronine to levothyroxine therapy in certain hypothyroid patients who do not achieve full symptom relief on levothyroxine alone [1].
---
Sources
1. https://www.drugs.com/liothyronine.html
2. https://drugpatentwatch.com/